ANI Pharma Inc | Business Contracts

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on August 8, 2022)

Asset Purchase Agreement between Holmdel Pharmaceuticals, LP and ANI Pharmaceuticals, Inc (Filed With SEC on May 10, 2022)

(Filed With SEC on March 15, 2022)

Registration Rights Schedule to the Merger Agreement, effective as of November 19, 2021 (Filed With SEC on November 26, 2021)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 15, 2022)

ANI Pharmaceuticals, Inc. Executive Incentive Bonus Plan (Filed With SEC on February 28, 2022)

Form of Option Agreement (Filed With SEC on March 11, 2021)

Description of Securities (Filed With SEC on March 11, 2021)

ANI Pharmaceuticals, Inc. Sixth Amended and Restated 2008 Incentive Plan (Filed With SEC on August 6, 2020)

Asset Purchase Agreement between Amerigen Pharmaceuticals LTD. and ANI Pharmaceuticals, Inc (Filed With SEC on February 27, 2020)

Form of Non- Statutory Stock Option Agreement (Filed With SEC on February 27, 2020)

Form of Incentive Option Agreement (Filed With SEC on February 27, 2020)

Form of Restricted Stock Grant Agreement (Filed With SEC on February 27, 2020)

Employment Agreement, entered into by the Company and James G. Marken (Filed With SEC on January 22, 2020)

Employment Agreement, entered into by the Company and Robert Schrepfer (Filed With SEC on January 22, 2020)

Employment Agreement, entered into by the Company and Stephen P. Carey (Filed With SEC on January 22, 2020)

Employment Agreement, entered into by the Company and Arthur S. Przybyl (Filed With SEC on January 22, 2020)

ANI Pharma Inc (29)